Kevin Balthaser
Vermogen: 852 911 $ op 31-05-2026
Vermogen: 852 911 $ op 31-05-2026
Kevin Balthaser currently holds the position of Chief Financial Officer & Accounting Officer at Aclaris Therapeutics, Inc. since 2023 and has been with the company since 2017.
Kevin is also a member of The American Institute of Certified Public Accountants.
Mr. Balthaser completed undergraduate studies at The Pennsylvania State University and earned an MBA from Villanova University in 1990.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 14-04-2026 | 187.453 ( 0,13% ) | 852 911 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ACLARIS THERAPEUTICS, INC. | Financieel Directeur/CFO | 01-01-2023 |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Aclaris Therapeutics, Inc.
Aclaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel drug candidates for immuno-inflammatory diseases | Health Technology |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Commercial Services |
The Pennsylvania State University
The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Villanova University
Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau